Sequent Scientific Limited
Sequent Scientific is India's leading animal health company, with presence in 5+ continents across 100 countries. Sequent Scientific Limited provides a wide-ranging portfolio of animal health products, including Finished Dose Formulations, APIs, as well as analytical services to the pharmaceutical and life sciences industries.
What Sequent files
- Others49
- Important25
- Updates19
- Investor Meet18
- Board Meeting9
- PPTs5
Viyash Scientific's subsidiary, Alivira Animal Health, partnered with Boehringer Ingelheim for companion animal product distribution in India. This strategic move aims to capture India's growing pet healthcare market and enhance market reach.
Sequent Scientific Limited will soon be known as Viyash Scientific Limited, with its trading symbol changing to VIYASH. This significant operational update reflects a business development for the company.
Sequent Scientific Limited has officially changed its name to Viyash Scientific Limited after receiving all necessary approvals. This business development is now complete, with filings underway at stock exchanges. Investors note the new identity.
SeQuent Scientific allotted 1,00,000 equity shares at Rs. 86 each under its ESOP. This increases the paid-up equity share capital from Rs. 87.21 Cr to Rs. 87.23 Cr, resulting in 43.61 Cr total shares.
Sequent's amalgamation scheme is effective. The board allotted 18.19 Cr shares and 2.03 Cr warrants, receiving 92.52 Cr upfront. Paid-up capital is now 87.21 Cr. Dr. Haribabu Bodepudi appointed MD & Group CEO, and Ramakant Singani as new CFO.